共 633 条
[1]
Goetz CG(2000)Amyotrophic lateral sclerosis: early contributions of Jean Martin Charcot Muscle Nerve 23 336-343
[2]
Zarei S(2015)A comprehensive review of amyotrophic lateral sclerosis Surg Neurol Int 7 247-251
[3]
Carr K(2006)Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study) Amyotroph Lateral Scler 18 271-280
[4]
Reiley L(2012)Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst Rev 82 623-627
[5]
Yoshino H(1985)Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management Ann Neurol 14 347-357
[6]
Kimura A(2011)Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis J Neurol Neurosurg Psychiatry 3 180-256
[7]
Miller RG(1987)Guam ALS/Parkinsonism-Dementia: a long-latency neurotoxic disorder caused by “slow toxin(s)” in food? Can J Neurol Sci 72 245-268
[8]
Mitchell JD(2012)Western Pacific ALS-PDC: a prototypical neurodegenerative disorder linked to DNA damage and aberrant proteogenesis? Front Neurol 72 257-62
[9]
Moore DH(2011)Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 362 59-630
[10]
Tandan R(2011)A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 7 616-2074